SNORA61: A Potential Drug Target and Biomarker (G677838)

Target Name: SNORA61

NCBI ID: G677838

SNORA61

Other Name(s): ACA61 | small nucleolar RNA, H/ACA box 61 | Small nucleolar RNA, H/ACA box 61

SNORA61: A Potential Drug Target and Biomarker

SNORA61 (ACA61) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of theSnor family of proteins, which are involved in various cellular processes, including cell signaling, DNA replication , and metabolism. SNORA61 has been identified as a potential drug target (or biomarker) due to its unique structure and the involvement of various cellular processes.

SNORA61 is a transmembrane protein that is expressed in the brain, heart, and liver. It is characterized by a unique extracellular domain that is composed of a hexagonal loop and a linear region. The hexagonal loop is responsible for the protein's stability and localization to the membrane, while the linear region is involved in various signaling processes.

SNORA61 is involved in various cellular processes that are critical for the normal functioning of the brain and the body. For example, it is involved in the regulation of cell signaling, which is critical for the development and maintenance of neural networks and other cellular processes that are responsible for brain function. Additionally, SNORA61 is involved in the regulation of DNA replication, which is critical for the maintenance of genetic integrity and the development of new cells.

SNORA61 has also been identified as a potential drug target due to its involvement in the regulation of cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. For example, SNORA61 has been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to the brain and other organs.

In addition to its involvement in cellular processes, SNORA61 has also been shown to play a role in the regulation of cellular interactions with the environment. For example, it is involved in the regulation of adhesion, which is the process by which cells stick together and form tissues. This is important for the development and maintenance of tissues and organs, including the brain and heart.

SNORA61 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This is because it is expressed in these diseases and has been shown to be involved in the regulation of various cellular processes that are associated with these diseases. For example, SNORA61 has been shown to be involved in the regulation of angiogenesis, which is a process that is critical for the development of new blood vessels in the brain and other organs.

In conclusion, SNORA61 is a protein that is expressed in various tissues of the body and is involved in various cellular processes that are critical for the normal functioning of the brain and the body. It is a potential drug target due to its unique structure and the involvement of various cellular processes that are associated with various diseases. Further research is needed to fully understand the role of SNORA61 in cellular processes and its potential as a drug target.

Protein Name: Small Nucleolar RNA, H/ACA Box 61

The "SNORA61 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA61 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets